Blog - Page 235 of 5637 - QualityStocks

FridayAug 08, 2025 3:22 pm

QualityStocksNewsBreaks – Spotlight on ONAR Holding Corp.’s (ONAR) Strategic Playbook: AI-Optimized Campaigns

ONAR (OTCQB: ONAR) was featured in a recent article that discussed its strategy amid the AI era in marketing. “For years, speed was king in digital marketing. Agencies raced to deploy campaigns, iterate quickly, and exploit trends before they faded. But in 2025, this ‘move fast and break things’ mindset is showing its limits. The rise of AI and the complexity of today’s customer journeys require more than just agility; they demand a strategic foundation that connects data, technology, and creativity in a measurable way,” the publication reads. “That shift is giving rise to a new class of agencies focused less…

FridayAug 08, 2025 3:09 pm

QualityStocksNewsBreaks – Why AI Maverick Intel Inc. (BINP) Is ‘One to Watch’

AI Maverick Intel (OTCID: BINP) recently rebranded and adopted a new strategic direction focused on AI-powered customer acquisition and automated sales engagement. The company was featured in a recent article that describes its vision “to eliminate friction from the customer acquisition process by replacing traditional, resource-heavy outreach with intelligent, automated engagement. Its mission is to empower organizations to connect with their ideal audiences at high velocity, using real-time insights and personalized communication powered by machine learning. AI Maverick Intel is committed to creating long-term value through innovation, efficiency, and strategic partnerships that enhance operational performance and accelerate growth.” To view…

FridayAug 08, 2025 11:25 am

QualityStocksNewsBreaks – Mega Fortune Company Limited (NASDAQ: MGRT) Closes $15 Million Initial Public Offering

Mega Fortune Company (NASDAQ: MGRT), an Internet of Things (“IoT”) solution provider in Hong Kong, closed its initial public offering of 3,750,000 ordinary shares at $4.00 per share, raising $15 million in gross proceeds before underwriting discounts and expenses. The shares began trading on the Nasdaq Capital Market on July 16, 2025. The company granted the underwriter a 45-day option to purchase up to an additional 562,500 ordinary shares at the public offering price. D. Boral Capital LLC acted as sole bookrunner for the offering. To view the full announcement, visit https://ibn.fm/f26ps About Mega Fortune Company Limited Mega Fortune Company Limited…

FridayAug 08, 2025 11:15 am

Brera Holdings PLC’s (NASDAQ: BREA) Becomes Second Multi-Club Owner in Italy’s Serie B, Signaling Rising Investment Opportunity

Brera Holdings joins City Football Group, owners of Premier League club Manchester City, as the only multi-club owners in Italy’s Serie B. The company owns SS Juve Stabia, which recorded a 245% increase in market value during the 2024-25 season. Juve Stabia reached the semifinals of the Serie A promotion playoffs following a strong campaign. The company has expanded into Europe, Africa, and Asia with strategic acquisitions since 2023. Juve Stabia acquisition was finalized on June 20, 2025, marking a major step in Brera’s MCO strategy. Brera Holdings (NASDAQ: BREA), an Ireland-based international holding company focused on expanding its global…

FridayAug 08, 2025 10:55 am

QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics(TM) Secures Florida Regulatory Clearance to Close Dura Medical Acquisition

NRx Pharmaceuticals (NASDAQ: NRXP), through its wholly owned subsidiary HOPE Therapeutics(TM), Inc., announced it has received final clearance from the Florida Agency for Health Care Administration to proceed with closing its acquisition of revenue-generating, EBITDA-positive Dura Medical LLC, pending customary conditions. Founded in 2018, Dura operates clinics on Florida’s west coast specializing in mental health and chronic pain treatment, offering Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), Spravato(R), Stellate Ganglion Blocks, and Traumatic Incident Reduction Therapy. The company also serves veterans through the Veterans Affairs Community Cares Network. HOPE leaders said the acquisition will expand its Florida network and integrate…

FridayAug 08, 2025 10:30 am

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Secures Financing Advisors, Expands Offerings to Fund Beacon Gold Mill Restart

LaFleur Minerals has engaged FMI Securities and FM Global Markets to raise up to C$5 million in debt financing. The capital will be used to restart production at their fully permitted Beacon Gold Mill in Val-d'Or, Québec. The company also launched two equity offerings: a LIFE private placement and a charity flow-through unit offering, which together could raise over C$5.4 million in additional capital. LaFleur's strategy focuses on near-term production at its Beacon Gold Mill, sourcing material from the Swanson Gold Deposit and other surrounding projects, highlighted by current gold prices and production-ready infrastructure as key advantages. LaFleur Minerals (CSE:…

FridayAug 08, 2025 9:45 am

ONAR Holding Corp. (ONAR) Expands AI Capabilities Through IQSTEL Partnership to Launch Multiagentic Infrastructure

Interconnected network of AI agents fundamentally transforms how marketing agencies create value and scale their impact The infrastructure will be introduced in three key phases: operational streamlining, strategic enablement and creative augmentation ONAR’s sees collaboration as foundational to the company’s long-term vision of building an advanced AI-powered agency system ONAR Holding Corp. (OTCQB: ONAR), a marketing technology company focused on AI-powered growth solutions, has announced the expansion of its strategic partnership with IQSTEL Inc. (NASDAQ: IQST) and IQSTEL’s artificial intelligence subsidiary, Reality Border (ibn.fm/whT2b). The collaboration will lead to the development and phased rollout of a multiagentic operating infrastructure designed…

FridayAug 08, 2025 9:30 am

QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures FDA Type C Meeting for AVERSA(TM) Fentanyl Abuse-Deterrent Patch

Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, announced the U.S. Food and Drug Administration has granted a Type C Meeting on Sept. 18, 2025, to review Chemistry, Manufacturing, and Controls plans for its lead product, AVERSA(TM) Fentanyl. Developed in partnership with Kindeva, the patch integrates Nutriband’s abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch to help prevent abuse, diversion, misuse, and accidental exposure while maintaining access for patients in need. Positioned to be the world’s first abuse-deterrent opioid patch, AVERSA Fentanyl targets peak annual U.S. sales potential of $80 million to $200 million, with future global market expansion…

FridayAug 08, 2025 9:20 am

QualityStocksNewsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Launches Sports.com Studios With GOATS Entertainment in Revenue-Driven Content Partnership

SEGG Media (NASDAQ: SEGG, LTRYW), through its original content division Sports.com Studios Ltd, has entered a co-production alliance with GOATS Entertainment, the premium storytelling brand co-founded by filmmaker Kevin Kaufman and entertainment executive Joe DiMuro. The partnership will transform the legacies of elite athletes into monetizable assets through docuseries, exclusive merchandise, global fan activations, and immersive storytelling, driving high-margin revenue streams across OTT, e-commerce, experiential, and licensing channels. GOATS brings an archive of over 90,000 iconic sports photographs by Walter Iooss Jr. and exclusive filmed interviews with more than 25 legendary athletes, including Kobe Bryant, Tiger Woods, Joe Montana, and…

FridayAug 08, 2025 9:00 am

Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF): The Cancer Detection Revolution That Could Make Breast Cancer Deaths Preventable

Izotropic's IzoView Breast CT Imaging System represents a breakthrough in dedicated breast imaging technology, addressing persistent limitations in conventional screening methods through proprietary hardware and software FDA regulatory pathway alignment clears the path for a pivotal U.S. clinical study, with the company completing a comprehensive 150-page strategic business plan and advanced financial modeling for commercialization Strategic awareness initiatives including dedicated breastct.com platform and podcast series position the company for market education as breast CT technology emerges as the next generation of cancer detection The medical community stands at the threshold of what could become the most significant advancement in cancer…

Site Search

Company Search